Inhibition of a lower potency target drives the anticancer activity of a clinical p38 inhibitor.
Bhattacharjee D, Bakar J, Chitnis SP, Sausville EL, Ashtekar KD, Mendelson BE, Long K, Smith JC, Heppner DE, Sheltzer JM.
Bhattacharjee D, et al. Among authors: mendelson be.
Cell Chem Biol. 2023 Oct 19;30(10):1211-1222.e5. doi: 10.1016/j.chembiol.2023.09.013. Epub 2023 Oct 11.
Cell Chem Biol. 2023.
PMID: 37827156
Free PMC article.